Clinical Trial Update: Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effectiveness and safety of intravenous Zemplar (paricalcitol) in patients on hemodialysis with secondary hyperparathyroidism, usin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypercalcemia
• Hyperparathyroidism

Drugs mentioned

• Zemplar (Paricalcitol)

Snippet

Sponsor: Abbott | Conditions: Secondary Hyperparathyroidism, Renal Insufficiency, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2011-10-31